Prothena Corp Public (PRTA) Other Accumulated Expenses (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Other Accumulated Expenses of $10.5 million in Q1 2026, down 10.92% quarter-over-quarter from $11.8 million in Q4 2025, and up 13.8% on a YoY basis from $9.2 million in Q1 2025.
Prothena Corp Public (PRTA) Other Accumulated Expenses (2012 - 2026) Analysis & Trends
Prothena Corp Public's Other Accumulated Expenses history runs 15 years deep, the most recent figure standing at $10.5 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 13.8% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $10.5 million (up 13.8% YoY), while the FY2025 annual figure was $11.8 million, down 25.61% from the prior year.
- Other Accumulated Expenses was $10.5 million for Q1 2026 at Prothena Corp Public, down from $11.8 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $15.8 million in Q4 2024 to a low of $5.0 million in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $10.7 million across 5 years, with a median of $10.5 million in 2026.
- The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses surged 78.73% in 2022, then plunged 42.61% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $12.2 million in 2022, then advanced by 28.71% to $15.7 million in 2023, then rose by 1.16% to $15.8 million in 2024, then declined by 25.61% to $11.8 million in 2025, then declined by 10.92% to $10.5 million in 2026.
- The last three Other Accumulated Expenses figures came in at $10.5 million (Q1 2026), $11.8 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.50 Mn |
| Dec 31, 2025 | 11.79 Mn |
| Sep 30, 2025 | 8.21 Mn |
| Jun 30, 2025 | 6.40 Mn |
| Mar 31, 2025 | 9.23 Mn |
| Dec 31, 2024 | 15.84 Mn |
| Sep 30, 2024 | 14.31 Mn |
| Jun 30, 2024 | 10.93 Mn |
| Mar 31, 2024 | 9.13 Mn |
| Dec 31, 2023 | 15.66 Mn |
| Sep 30, 2023 | 13.78 Mn |
| Jun 30, 2023 | 10.22 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | 12.17 Mn |
| Sep 30, 2022 | 13.17 Mn |
| Jun 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 4.96 Mn |
| Dec 31, 2021 | 9.81 Mn |
| Sep 30, 2021 | 7.37 Mn |
| Jun 30, 2021 | 7.94 Mn |